Evidence map›Paper›PMID 42697191›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

Therapy-induced IGF1R signaling as an actionable vulnerability in oncolytic virotherapy.

Alexandra A Miller, Tae Jin Lee, Ji Young Yoo

Abstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexandra A MillerDepartment of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX 77225, USA.
Tae Jin LeeDepartment of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX 77225, USA. Electronic address: tae.jin.lee@uth.tmc.edu.
Ji Young YooDepartment of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX 77225, USA. Electronic address: ji.young.yoo@uth.tmc.edu.

Funding

Enhanced Viro-Immunotherapy for Breast Cancer Brain MetastasisR01CA276942 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Ji Young Yoo · 2023 to 2026
$2.2M
IGF1R-targeted oncolytic herpes simplex viral therapy for GlioblastomaR21NS123685 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YOO, JI YOUNG · 2022 to 2023
$405k
NCI NIH HHS R01 CA276942NINDS NIH HHS R21 NS123685
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42697191
PMCPMC13602385

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.